All data are based on the daily closing price as of December 24, 2024
k

KOBAYASHI Pharmaceutical

4967.TSE
38.15 USD
-0.13
-0.34%

Overview

Last close
38.15 usd
Market cap
2.84B usd
52 week high
55.65 usd
52 week low
32.22 usd
Target price
37.86 usd

Valuation

P/E
43.6997
Forward P/E
N/A
Price/Sales
2.6384
Price/Book Value
2.1652
Enterprise Value
2.50B usd
EV/Revenue
2.3253
EV/EBITDA
28.5895

Key financials

Revenue TTM
1.08B usd
Gross Profit TTM
588.10M usd
EBITDA TTM
189.73M usd
Earnings per Share
0.87 usd
Dividend
0.37 usd
Total assets
1.63B usd
Net debt
-316.69M usd

About

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese medicine; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air freshener, lens cleaner, cooling gel sheets, and oral hygiene products. It also manufactures and sells pharmaceuticals, cosmetics, and health foods; and manufactures and sells synthetic resin products; markets nutritional supplements and skin care products through mail orders; and sells skincare products, daily necessities, and health foods, as well as manufactures body warmers. In addition, the company engages in transportation, real estate management, and advertising planning and production businesses; manufacture of sanitary and paper products; and asset management. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
  • Symbol
    4967.TSE
  • Exchange
    TSE
  • Isin
    JP3301100008
  • Country
    Japan
  • Sector
    Consumer Defensive
  • Industry
    Household & Personal Products
  • CEO
    Mr. Kazumasa Kobayashi
  • Headquarter
    Osaka
  • Web site
    https://www.kobayashi.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top